Price loading...

The 2013-2018 Outlook for Renal Cell Carcinoma (RCC) Drugs in the United States

Price data last checked 93 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
17 July 2013
Listed Since
23 July 2013

Similar Products You Might Like

The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean
96% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2023-2028 Outlook for Kidney Cancer Drugs in the United States
96% match

The 2023-2028 Outlook for Kidney Cancer Drugs in the United States

£520.00 13 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Oceana

£325.00 28 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Europe

£325.00 24 Jan 2026
The 2013-2018 Outlook for Cell-Based Assays in the United States
95% match

The 2013-2018 Outlook for Cell-Based Assays in the United States

£495.00 09 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East

£325.00 25 Mar 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Africa & the Middle East

£325.00 24 Jan 2026
The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America
95% match

The 2013-2018 Outlook for Pancreatic Cancer Drugs in Latin America

£325.00 29 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia

£325.00 31 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
95% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean
95% match

The 2013-2018 Outlook for Drug Discovery Technologies in North America & the Caribbean

£325.00 26 Mar 2026
The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States
95% match

The 2013-2018 Outlook for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in the United States

£495.00 08 Jan 2026
The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa
95% match

The 2013-2018 Outlook for Prostate Cancer Therapeutics in Africa

£325.00 06 Feb 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
94% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026
The 2013-2018 Outlook for Drugs in India
94% match

The 2013-2018 Outlook for Drugs in India

£495.00 16 Dec 2025
The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean
94% match

The 2013-2018 Outlook for Ophthalmic Pharmaceutical Drugs in North America & the Caribbean

£325.00 28 Jan 2026
The 2013-2018 Outlook for Metabolomics in the United States
94% match

The 2013-2018 Outlook for Metabolomics in the United States

£495.00 07 Jan 2026
The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in the United States
94% match

The 2013-2018 Outlook for Testosterone Replacement Therapy (TRT) in the United States

£495.00 11 Jan 2026
The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa
94% match

The 2013-2018 Outlook for Multiple Myeloma Therapeutics in Africa

£325.00 08 Feb 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs for US Zip Codes
94% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs for US Zip Codes

£490.00 24 Jan 2026
The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean
94% match

The 2013-2018 Outlook for Erythropoietins in North America & the Caribbean

£325.00 21 Jan 2026
The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean
94% match

The 2013-2018 Outlook for Small Molecule Kinase Inhibitors in North America & the Caribbean

£325.00 29 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in China
94% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in China

£495.00 08 Mar 2026
The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean
94% match

The 2013-2018 Outlook for Psoriasis Drugs in North America & the Caribbean

£325.00 28 Jan 2026